Guizuo Wang
Xi'an Jiaotong University
34 Papers
107 Citations
Guizuo Wang is an academic researcher from Xi'an Jiaotong University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 10, co-authored 17 publications.
Chat about Author
Papers
Activation of AMPK inhibits pulmonary arterial smooth muscle cells proliferation.
Yuanyuan Wu,Lu Liu,Yonghong Zhang,Guizuo Wang,Dong Han,Rui Ke,Shaojun Li,Wei Feng,Manxiang Li +8 more
TL;DR: The study suggests that activation of AMPK suppresses PASMCs proliferation and has potential value in negatively modulating pulmonary vascular remodeling and therefore could prevent or treat the development of pulmonary arterial hypertension (PAH).
45
A novel hypothesis: up-regulation of HO-1 by activation of PPARγ inhibits HMGB1-RAGE signaling pathway and ameliorates the development of ALI/ARDS.
TL;DR: The hypothesis that HO-1 may mediate the protective effects of PPARγ on inhibition of HMGB1-RAGE signaling pathway to attenuate the development of ALI/ARDS is proposed.
32
Benefits of continuous positive airway pressure on blood pressure in patients with hypertension and obstructive sleep apnea: a meta-analysis
TL;DR: Continuous positive airway pressure treatment significantly lowered 24-h systolic and diastolic blood pressure in patients with hypertension and obstructive sleep apnea, except when the follow-up period was shorter than 3 months.
25
The safety of long-term use of inhaled corticosteroids in patients with asthma: A systematic review and meta-analysis.
TL;DR: In this paper , a systematic review and meta-analysis was performed to determine the safety of long-term use of ICS in patients with asthma, which was made of PubMed, Embase, Web of Science, Cochrane Library, and clinicaltrials.gov.
24
Statins inhibit pulmonary artery smooth muscle cell proliferation by upregulation of HO-1 and p21WAF1.
Manxiang Li,Yuan Liu,Hongyang Shi,Yonghong Zhang,Guizuo Wang,Jing Xu,Jiamei Lu,Dexin Zhang,Xinming Xie,Dong Han,Yuanyuan Wu,Shaojun Li +11 more
TL;DR: This study suggests that simvastatin inhibits PASMCs proliferation by sequential upregulation of HO-1 and p21WAF1 to benefit pulmonary hypertension.
23